Progress in the Development of Antibody–Drug Conjugates Targeting TROP-2 for Advanced NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
From Congress to Clinic: A Post-JSMO Update on Novel Antibody–Drug Conjugates and Other Agents Targeting HER3 in NSCLC

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
FAQs: Novel Antibody–Drug Conjugates and Other Agents Targeting HER3 in NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Therapeutic Relevance of HER3 in EGFR TKI-Resistant NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--